Anixa Biosciences develops cancer therapies and vaccines, mainly for ovarian and breast cancer, and is based in San Jose, California. ANIX reports earnings on Mon, Jan 11, 2027.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 22 | HC Wainwright & Co. | Maintained | Buy | |
| Jun 30 | D. Boral Capital | Assumed coverage | Buy |
Seasonality
How ANIX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in ANIX in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANIX is in one of them and how their past ANIX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ANIX in an article yet. Here's the latest on the wider market.
About Anixa Biosciences
Anixa Biosciences is a biotechnology company based in San Jose, California, that is developing cancer therapies and vaccines. Its main programs focus on ovarian cancer and breast cancer, including a cell therapy designed to treat ovarian cancer and a vaccine aimed at preventing and treating breast cancer. Its products are still being tested in clinical trials and are not yet available for sale.
- Headquarters
- San Jose, CA